Follicum is a pharmaceutical company. The greatest focus is on the development of drug candidates that stimulate hair growth in patients. Currently products are held that may stimulate hair growth, but also hamper the degree of hair growth, mainly derived from hirsutism, which implicates unusually large production of hair in women. The pharmaceutical consists of endogenous, human proteins, which influence the processing of hair follicles. The company was established in 2011 and is based in Lund.

Quotes for Follicum AB

Right Now

+/-
0.11
%
4,85%
Latest
2.38
High
2.38
Low
2.3
Volume
7 879
Turnover (SEK)
18 154
Value (MSEK)
100,4

Board

CEO

  • Jan Alenfall

Chairman Of The Board

  • Gun-Britt Fransson

Board

  • Alejandra Mørk
  • Anna Hultgårdh Nilsson
  • Jonas Edelswärd
  • Lars H. Bruzelius

Videos

Largest Owners

Name Capital % Votes % Date
Swedish Growth Fund 14,91 14,91 2019-03-31
Avanza Pension 9,79 9,79 2019-03-31
Mats Lundberg 3,23 3,23 2019-03-31
Nordnet Pensionsförsäkring 3,14 3,14 2019-03-31
Kudu AB 2,72 2,72 2019-03-31
Brushamn Invest AB 1,74 1,74 2019-03-31
Tibia Konsult AB 1,68 1,68 2019-03-31
Pontus Dunér 1,42 1,42 2019-03-31
Stiftelsen Akademihemman 1,42 1,42 2019-03-31
Atherioco AB 1,36 1,36 2019-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Inquiry Financial